Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering
Portfolio Pulse from Rounak Jain
Netherlands-based biotech startup Cradle, specializing in AI-powered protein design and engineering, has raised $24 million in Series A funding led by Index Ventures and Kindred Capital. Former Merck lead director Tom Glocer and Recursion co-founder Chris Gibson also invested. Cradle's technology accelerates R&D projects, including vaccines and antibodies, by leveraging generative AI and ML. The company plans to use the funds to expand its teams and invest in product development and sales. Alphabet's Google Brain alum Stef van Grieken is Cradle's co-founder and CEO. Pharmaceutical companies like Johnson & Johnson are also using generative AI for product engineering.
November 28, 2023 | 10:10 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Alphabet's Google Brain alum Stef van Grieken is the co-founder and CEO of Cradle, which has raised $24M for AI-powered protein design.
While the news reflects positively on the caliber of alumni emerging from Google Brain, it does not directly impact Alphabet's operations or financials. The relevance is moderate due to the association with a former employee, but the importance is low as it does not pertain to Alphabet's core business.
CONFIDENCE 80
IMPORTANCE 20
RELEVANCE 30
NEUTRAL IMPACT
Alphabet's Google Brain alum Stef van Grieken is the co-founder and CEO of Cradle, which has raised $24M for AI-powered protein design.
Similar to GOOG, the news about Cradle does not directly impact Alphabet's operations or financials. The relevance is moderate due to the association with a former employee, but the importance is low as it does not pertain to Alphabet's core business.
CONFIDENCE 80
IMPORTANCE 20
RELEVANCE 30
NEUTRAL IMPACT
Johnson & Johnson is mentioned as one of the pharmaceutical giants deploying generative AI technology similar to Cradle's for product engineering.
Johnson & Johnson's mention is in the context of the industry trend towards using generative AI, but the article does not provide specific details on JNJ's initiatives or outcomes. Therefore, the impact is neutral with low relevance and importance.
CONFIDENCE 70
IMPORTANCE 10
RELEVANCE 20
NEUTRAL IMPACT
Microsoft, backing OpenAI, is noted for popularizing generative AI, a field in which Cradle operates and has raised $24M for protein design.
Microsoft's involvement with OpenAI is mentioned to highlight the popularity of generative AI. However, the news about Cradle's funding does not directly affect Microsoft's short-term financials or operations, hence the neutral impact with low relevance and importance.
CONFIDENCE 70
IMPORTANCE 10
RELEVANCE 20